Biotech Snapshot During A Rally Day: No Summer Doldrums…
August 10, 2018 at 06:06 AM EDT
Biotech stocks were mixed trading closer to the flatline after the close on light summer volume. Macro issues such as drug pricing, trade and the Fed remain a concern.
